Mizuho cuts Lantheus target from USD 115.00 to USD 109.00 for Lantheus Holdings stock
Published on 10/17/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget revision precedes results
- Mizuho lowered its Lantheus target from USD 115.00 to USD 109.00 on October 13, 2026.
- Revenue was USD 388.18 million in the second quarter of 2026.
- Lantheus Holdings stock closed at USD 99.70 on October 16, 2026 at 4:00 p.m. ET, down 0.29 percent versus the Nasdaq prior close of USD 99.99.
- Lantheus is estimated to report third-quarter results on November 5, 2026.
Mizuho reaffirmed a Neutral rating on Lantheus and lowered its target from USD 115.00 to USD 109.00 on October 13, 2026, according to MarketBeat. The new target sits 9.33 percent above the Nasdaq closing price of USD 99.70 on October 16, 2026 at 4:00 p.m. ET. Lantheus Holdings stock was down 0.29 percent versus the prior close of USD 99.99.
Second-quarter revenue reached USD 388.18 million
Lantheus reported USD 388.18 million in revenue for the second quarter ended June 30, 2026, up 2.70 percent from the same quarter a year earlier. The company also reported USD 75.03 million in net income and diluted earnings per share of USD 1.11 for the period. MarketBeat said revenue exceeded the USD 363.23 million consensus estimate by USD 24.95 million.
Stock stays below its yearly high
The October 16 closing price of USD 99.70 stood 10.87 percent below the 52-week high of USD 111.86 and 98.90 percent above the 52-week low of USD 50.15. Trading volume was 1,711,569 shares, compared with an average of 1,353,218 shares, making the session volume 26.47 percent higher than average.
Valuation and November 5 results
Lantheus had a market capitalization of USD 6.5 billion and a price-to-earnings ratio of 24.08 as of October 16, 2026. The company is estimated to report third-quarter results on November 5, 2026, before the market opens, with an estimated revenue of USD 360.82 million and earnings per share of USD 1.26, according to MarketBeat.
Comparison with peers
LNTH (Nasdaq, USD): minus 0.29 percent, P/E 24.08, market capitalization USD 6.5 billion.
Thermo Fisher Scientific (NYSE, USD): minus 0.93 percent, P/E 37.12, market capitalization USD 255.1 billion.
Quest Diagnostics (NYSE, USD): minus 1.74 percent, P/E 24.95, market capitalization USD 25.9 billion.
Closing price sets the frame
The Nasdaq closing price was USD 99.70 on October 16, 2026 at 4:00 p.m. ET, down 0.29 percent versus the prior close of USD 99.99. The price was 10.87 percent below the 52-week high, while Mizuho's USD 109.00 target remained 9.33 percent above the close.
Lantheus Holdings stock facts
- Company: Lantheus Holdings, Inc.
- ISIN: US5165441032
- Ticker: LNTH
- Primary exchange: Nasdaq
- Price Nasdaq (as of October 16, 2026, 4:00 p.m. ET): USD 99.70
- Change versus prior Nasdaq close: minus 0.29 percent
- Market capitalization: USD 6.5 billion (as of October 16, 2026)
- 52-week range: USD 50.15-111.86 (as of October 16, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: November 5, 2026
Market context: Market report Nasdaq Composite.
